Literature DB >> 12393589

Specific inhibition of P-selectin-mediated cell adhesion by phage display-derived peptide antagonists.

Tom J M Molenaar1, Chantal C M Appeldoorn, Sonja A M de Haas, Ingrid N Michon, Arnaud Bonnefoy, Marc F Hoylaerts, Hans Pannekoek, Theo J C van Berkel, Johan Kuiper, Erik A L Biessen.   

Abstract

P-selectin is a leukocyte adhesion receptor expressed on activated vascular endothelium and platelets that mediates leukocyte rolling and attachment. Because P-selectin is critically involved in inflammation, we used phage display libraries to identify P-selectin-specific peptides that might interfere with its proinflammatory function. Isolated phage contained a highly conserved amino acid motif. Synthetic peptides showed calcium-dependent binding to P-selectin, with high selectivity over E-selectin and L-selectin. The peptides completely antagonized adhesion of monocyte-derived HL60 cells to P-selectin and increased their rolling velocities in flow chamber experiments. Peptide truncation and alanine-scanning studies indicated that an EWVDV (single-letter amino acid codes) consensus motif sufficed for effective inhibition. Intriguingly, the apparent avidity of the peptides was increased 200-fold when presented in a tetrameric form (2 microM versus 10 nM), which is consistent with the proposed divalent interaction of P-selectin glycoprotein ligand 1 (PSGL-1) with P-selectin. As the EWVDV peptides inhibit the binding of an established glycoside ligand for P-selectin (sulfated Lewis A), it is conceivable that EWVDV interacts with or in close proximity to the actual carbohydrate recognition domain of P-selectin, without being a direct structural mimic of sialyl Lewis(x). These ligands are among the most potent antagonists of P-selectin yet designed. Their high affinity, selectivity, and accessible synthesis provide a promising entry to the development of new anti-inflammatory therapeutics and might be a powerful tool to provide important information on the binding site of P-selectin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393589     DOI: 10.1182/blood-2002-02-0641

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands.

Authors:  P M Peiris; F He; G Covarrubias; S Raghunathan; O Turan; M Lorkowski; B Gnanasambandam; C Wu; W P Schiemann; E Karathanasis
Journal:  Nanoscale       Date:  2018-04-19       Impact factor: 7.790

2.  Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44.

Authors:  Dina B AbuSamra; Fajr A Aleisa; Asma S Al-Amoodi; Heba M Jalal Ahmed; Chee Jia Chin; Ayman F Abuelela; Ptissam Bergam; Rachid Sougrat; Jasmeen S Merzaban
Journal:  Blood Adv       Date:  2017-12-26

3.  Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.

Authors:  Shingo Hatakeyama; Kazuhiro Sugihara; Toshiaki K Shibata; Jun Nakayama; Tomoya O Akama; Naoaki Tamura; Shuk-Man Wong; Andrey A Bobkov; Yutaka Takano; Chikara Ohyama; Minoru Fukuda; Michiko N Fukuda
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-23       Impact factor: 11.205

Review 4.  Systems approaches to design of targeted therapeutic delivery.

Authors:  Jacob W Myerson; Jacob S Brenner; Colin F Greineder; Vladimir R Muzykantov
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2015-05-06

5.  Quantitative Characterization of E-selectin Interaction with Native CD44 and P-selectin Glycoprotein Ligand-1 (PSGL-1) Using a Real Time Immunoprecipitation-based Binding Assay.

Authors:  Dina B AbuSamra; Alia Al-Kilani; Samir M Hamdan; Kosuke Sakashita; Samah Z Gadhoum; Jasmeen S Merzaban
Journal:  J Biol Chem       Date:  2015-06-29       Impact factor: 5.157

6.  Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis.

Authors:  Elizabeth Doolittle; Pubudu M Peiris; Gilad Doron; Amy Goldberg; Samantha Tucci; Swetha Rao; Shruti Shah; Meilyn Sylvestre; Priya Govender; Oguz Turan; Zhenghong Lee; William P Schiemann; Efstathios Karathanasis
Journal:  ACS Nano       Date:  2015-07-28       Impact factor: 15.881

7.  Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cells.

Authors:  Shingo Hatakeyama; Kazuhiro Sugihara; Jun Nakayama; Tomoya O Akama; Shuk-Man Annie Wong; Hiroto Kawashima; Jianing Zhang; David F Smith; Chikara Ohyama; Minoru Fukuda; Michiko N Fukuda
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

Review 8.  Experimental models investigating the inflammatory basis of atherosclerosis.

Authors:  Ahmed Soliman; Patrick Kee
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

9.  A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms.

Authors:  Christa L Modery-Pawlowski; Alyssa M Master; Victor Pan; Gregory P Howard; Anirban Sen Gupta
Journal:  Biomacromolecules       Date:  2013-02-14       Impact factor: 6.988

Review 10.  Novel uses for anti-platelet agents as anti-inflammatory drugs.

Authors:  S C Pitchford
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.